Literature DB >> 32097466

Cannabinoids in the Treatment of Back Pain.

Teddy E Kim1, Robert K Townsend1, Charles L Branch1, Edgar A Romero-Sandoval2, Wesley Hsu1.   

Abstract

Marijuana is increasingly utilized for the treatment of multiple medical problems, including back pain, in the United States. Although there is strong preclinical evidence supporting the promise of cannabinoids in the treatment of back pain, there is a paucity of clinical data supporting their use in clinical practice. Opioids are an important medication for the treatment of acute and chronic back pain, but utilization of opioid-based regimens have likely contributed to the growing opioid epidemic. The significant risk of morbidity, mortality, and dependence secondary to opioid medications have increased the interest in nonopioid medications, including cannabinoid-based pain regimens, in treating back pain. This review will provide an overview on the pharmacology, drug delivery methods, clinical evidence, and safety considerations critical to understanding the potential role of cannabinoids in the treatment of back pain.
Copyright © 2020 by the Congress of Neurological Surgeons.

Entities:  

Keywords:  Back pain; CBD; Cannabidiol; Cannabinoid; Inflammation; Marijuana; Neuropathy; Opioid epidemic; Postoperative pain; THC; Δ9-Tetrahydrocannabinol

Mesh:

Substances:

Year:  2020        PMID: 32097466     DOI: 10.1093/neuros/nyz573

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  3 in total

Review 1.  Analyzing the Impact of Cannabinoids on the Treatment of Spinal Disorders.

Authors:  Rohan M Shah; Anjay Saklecha; Alpesh A Patel; Srikanth N Divi
Journal:  Curr Rev Musculoskelet Med       Date:  2022-02-08

2.  Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting Opioid Analgesics in Patients with Severe Neuropathic Back Pain: Analysis of 6-Month Real-World Data from the German Pain e-Registry.

Authors:  Michael A Ueberall; Carlos Vila Silván; Ute Essner; Gerhard H H Mueller-Schwefe
Journal:  Pain Med       Date:  2022-04-08       Impact factor: 3.750

Review 3.  Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse.

Authors:  Antonelly Cassio Alves de Carvalho; Gabriela Achete de Souza; Samylla Vaz de Marqui; Élen Landgraf Guiguer; Adriano Cressoni Araújo; Claudio José Rubira; Ricardo de Alvares Goulart; Uri Adrian Prync Flato; Patricia Cincotto Dos Santos Bueno; Rogério Leone Buchaim; Sandra M Barbalho
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.